Duke logo

Color Study for Genetic Testing - Clinical Trial

What is the Purpose of this Study?

We are doing this study to screen women diagnosed with high-risk breast lesions for genetic mutations that may be linked to a future risk of cancer.

What is the Condition Being Studied?

Genetic Testing

Who Can Participate in the Study?

Women diagnosed with high-risk breast lesions including:
- Lobular carcinoma in situ (LCIS)
- Atypical ductal hyperplasia (ADH)
- Atypical lobular hyperplasia (ALH)
- Flat epithelial atypia (FEA)
- Columnar cell hyperplasia (CCH)

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Give a saliva sample
- Have a genetic testing using the Color Genomics 30 gene hereditary panel test

Study Details

Full Title
Genetic testing for women with high-risk breast lesions
Principal Investigator
Surgical Oncologist
Protocol Number
IRB:PRO00089223
NCT:NCT00000000
Phase
Phase N/A
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698